Trump Scores Big Win in UK Drug Deal

UNLEASH PROSPERITY

Six months ago, our 501 (c)(4) partner organization Unleash Prosperity Now, launched a project called Most Favored Patient that was designed to steer Trump away from dangerous drug price controls. Instead, we designed a plan that would force other free-loading nations of Europe and Asia to stop free-riding on American pharmaceutical innovation.

The reflexive solution would be for the US to adopt similar price controls, which Trump was threatening, but this would’ve stunted the race for the cure for terrible diseases.

So we congratulate President Trump and US Trade Representative Jamieson Greer for accomplishing what we proposed as the best solution to this thorny problem: negotiate into trade agreements with other rich countries provisions that require them to pay more for innovative prescription drugs.  They have done just that with the UK:

Read more here.